Deals this week: Pfizer, Peakdale Molecular, Selexis

Pfizer and National Cancer Institute have entered a co-operative research and development (R&D) agreement to develop novel immunotherapy candidates targeting multiple cancers.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news